News
SNN
30.49
+2.96%
0.88
Smith & Nephew price target lowered to 1,333 GBp at Morgan Stanley
TipRanks · 21h ago
Analyst Reiterates Buy on Smith & Nephew, Citing Earnings Recovery Upside Despite Cutting Price Target to £13.33
TipRanks · 1d ago
Weekly Report: what happened at SNN last week (0615-0619)?
Weekly Report · 2d ago
Barclays Remains a Hold on Smith & Nephew (SN)
TipRanks · 2d ago
Bioretec names Conan Cavanagh as R&D chief, executive team member
PUBT · 06/17 13:01
Cevian Capital Lifts Smith & Nephew Stake to 12.24% Without Triggering New Threshold
TipRanks · 06/17 10:54
Press Release: Fresh Off Its Nasdaq Debut, a -2-
Dow Jones · 06/16 12:15
Press Release: Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
Dow Jones · 06/16 12:15
Weekly Report: what happened at SNN last week (0608-0612)?
Weekly Report · 06/15 10:30
Analyst Maintains Buy on Smith & Nephew as Knee Franchise Recovery and Diversified Growth Support Trimmed 1,450 GBp Price Target
TipRanks · 06/11 12:56
Cevian Capital Lifts Smith & Nephew Stake Above 12% in June 2026
TipRanks · 06/11 10:56
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Align Tech (ALGN) and Smith & Nephew Snats (SNN)
TipRanks · 06/10 11:30
Smith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplasty
Barchart · 06/08 12:23
Weekly Report: what happened at SNN last week (0601-0605)?
Weekly Report · 06/08 10:26
Smith & Nephew Executives Reinvest 2025 Final Dividend Into ADS Purchases
TipRanks · 06/04 15:53
Smith & Nephew downgraded to Hold from Buy at Kepler Cheuvreux
TipRanks · 06/04 08:50
Smith & Nephew Executives Reinvest 2025 Final Dividend into Company Shares
TipRanks · 06/03 11:31
Smith & Nephew Lists €500m Long-Dated Notes on London Stock Exchange
TipRanks · 06/03 10:28
Goldman Sachs Sticks to Their Buy Rating for Smith & Nephew (SN)
TipRanks · 06/02 00:10
Smith & Nephew Updates Share Capital and Voting Rights as of 31 May 2026
TipRanks · 06/01 15:59
More
Webull provides a variety of real-time SNN stock news. You can receive the latest news about Smith & Nephew through multiple platforms. This information may help you make smarter investment decisions.
About SNN
Smith & Nephew plc is a portfolio medical technology company. The Company is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, which includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilize severe fractures and correct bone deformities; Sports Medicine & ENT businesses offer advanced products and instruments used to repair or remove soft tissue, and Advanced Wound Management provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds. The Company also owns Integrity Orthopaedics, which is an early stage commercial developer of Tendon Seam, an innovative and disruptive biomechanical RCR system.